(Q37221529)

19 August 2017

Pegaptanib sodium treatment in neovascular age-related macular degeneration: clinical experience in Germany (English)

1 reference

19 August 2017

0 references

1 reference

Nikolaus Feucht

1

1 reference

19 August 2017

Huebner Matthias

series ordinal

2

1 reference

19 August 2017

Chris P Lohmann

series ordinal

3

1 reference

19 August 2017

Mathias Maier

series ordinal

4

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

19 August 2017

Clinical Ophthalmology

1 reference

19 August 2017

2

1 reference

19 August 2017

2

1 reference

19 August 2017

253-259

1 reference

Intravitreal ranibizumab and bevacizumab: a review of risk

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693993

Quality of life in age-related macular degeneration: a review of the literature

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693993

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693993

Ranibizumab for neovascular age-related macular degeneration

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693993

Ranibizumab: Phase III clinical trial results

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693993

The role of vascular endothelial growth factor in ocular health and disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693993

VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693993

Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693993

Age-related macular disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693993

Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693993

Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693993

Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693993

Pegaptanib for neovascular age-related macular degeneration

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2693993

Acute retinal pigment epithelial tear in the untreated fellow eye following repeated bevacizumab (Avastin) injections

3 September 2018

1 reference

12 December 2020

[Comments on current therapeutic possibilities for neovascular age-related macula degeneration]

1 reference

12 December 2020

Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials

1 reference

12 December 2020

The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling

1 reference

12 December 2020

Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1

1 reference

12 December 2020

Identifiers

DOI

10.2147/OPTH.S2842

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

19668713

1 reference